DNAVision
ActiveSummary
DNAVision has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€879,841) and a net result of -€73,752. Equity is shrinking by ~13.3% per year across the filed fiscal years. Its solvency ranks better than 5% of 195 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability0=
Solvency0=
Growth32=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.03 against 0.06 in 2024; cash: 69.9% of total assets), and equity is negative.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Return on assets
-265.1%
Age of the figures
9 mo
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year -€879,841
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-09-2026, 52 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
52 d late
2024
50 d late
2023
29 d late
2022
31 d late
2021
74 d late
2020
143 d late
2019
122 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 72 days after the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€73,752▼ 195%
2024 · -€24,981
Working capital
-€879,841▼ 9.1%
2024 · -€806,089
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result-€130,580▲ 43.2%-€105,295▲ 19.4%-€30,983▲ 70.6%-€23,057▲ 25.6%-€72,117▼ 213%
Net result-€143,300below the sector's middle half▲ 38.9%-€103,712within the sector's middle half▲ 27.6%-€26,071within the sector's middle half▲ 74.9%-€24,981within the sector's middle half▲ 4.2%-€73,752within the sector's middle half▼ 195%
Equity-€651,326below the sector's middle half▼ 28.2%-€755,038below the sector's middle half▼ 15.9%-€781,109below the sector's middle half▼ 3.5%-€806,089below the sector's middle half▼ 3.2%-€879,841below the sector's middle half▼ 9.1%
Total assets€241,626below the sector's middle half▼ 11.1%€65,386below the sector's middle half▼ 72.9%€92,608below the sector's middle half▲ 41.6%€52,772below the sector's middle half▼ 43.0%€27,822below the sector's middle half▼ 47.3%
Debt€892,951▲ 14.5%€820,423▼ 8.1%€873,717▲ 6.5%€858,861▼ 1.7%€907,663▲ 5.7%
Working capital-€662,604below the sector's middle half▼ 24.2%-€759,658below the sector's middle half▼ 14.6%-€782,538below the sector's middle half▼ 3.0%-€806,089below the sector's middle half▼ 3.0%-€879,841below the sector's middle half▼ 9.1%
Solvency-269.6%below the sector's middle half▼ 82.5pp-843.5%below the sector's middle half
Current ratio0.26below the sector's middle half▼ 0.060.07below the sector's middle half▼ 0.180.10below the sector's middle half▲ 0.030.06below the sector's middle half▼ 0.040.03below the sector's middle half▼ 0.03
Return on assets (ROA)-59.3%below the sector's middle half▲ 27.1pp-158.6%below the sector's middle half▼ 99.3pp-28.2%below the sector's middle half▲ 130.5pp-47.3%below the sector's middle half▼ 19.2pp-265.1%below the sector's middle half▼ 217.7pp
Staff (FTE)4.6within the sector's middle half▼ 19.3%4.6within the sector's middle half=2below the sector's middle half▼ 56.5%2below the sector's middle half=2below the sector's middle half=
above
within
below
the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €72,117 in 2025 against €23,057 in 2024; the loss grows.
Key figures and ratios
Debt to equity
-1.03▲
2024 · -1.07
Debt ≤ 1 year
€907,663▲
2024 · €858,861
Income taxes
€195▲
2024 · €157
Staff costs
€67,986▲
2024 · €66,235
A ratio outside any meaningful range has been withheld (balance sheet total €27,822, equity -€879,841).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,639 companies that looked in July 2024 the way this one looks now, 4.1% went bankrupt within 24 months and 84% are still going.
- Micro
- 20 years or older
- negative equity
- a loss of 10% of the balance sheet or more
4.1%
went bankrupt
9.8%
stopped otherwise
84%
still going
A further 2.0% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.6% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,639 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €11,376 | - | - | - |
| Remuneration, social security and pensions62 | €229,946 | €115,442 | €65,665 | €66,235 | €67,986 | ▲ 2.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €6,291 | €6,659 | €3,191 | €1,429 | - | - |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | -€39,031 | - | - | - | - | - |
| Other operating charges640/8 | €39,378 | €21,893 | €384 | €387 | €400 | ▲ 3.2% |
| Gross operating margin9900 | €106,004 | €38,699 | €38,257 | €44,995 | -€3,731 | ▼ 108% |
| Operating profit (loss)9901 | -€130,580 | -€105,295 | -€30,983 | -€23,057 | -€72,117 | ▼ 213% |
| Financial income75/76B | €9 | €6,698 | €7,518 | €5 | - | - |
| Recurring financial income75 | €9 | €6,698 | €7,518 | €5 | - | - |
| Financial charges65/66B | €11,694 | €4,418 | €2,435 | €1,771 | €1,439 | ▼ 18.7% |
| Recurring financial charges65 | €11,694 | €4,418 | €2,435 | €1,771 | €1,439 | ▼ 18.7% |
| Profit (loss) for the period before taxes9903 | -€142,264 | -€103,015 | -€25,900 | -€24,823 | -€73,556 | ▼ 196% |
| Income taxes67/77 | €1,036 | €698 | €171 | €157 | €195 | ▲ 24.3% |
| Profit (loss) for the period9904 | -€143,300 | -€103,712 | -€26,071 | -€24,981 | -€73,752 | ▼ 195% |
| Profit (loss) for the period to be appropriated9905 | -€143,300 | -€103,712 | -€26,071 | -€24,981 | -€73,752 | ▼ 195% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €241,626 | €65,386 | €92,608 | €52,772 | €27,822 | ▼ 47.3% |
| Fixed assets21/28 | €11,279 | €4,620 | €1,429 | - | - | - |
| Tangible fixed assets22/27 | €11,279 | €4,620 | €1,429 | - | - | - |
| Plant, machinery and equipment23 | €11,279 | €4,620 | €1,429 | - | - | - |
| Current assets29/58 | €230,347 | €60,766 | €91,179 | €52,772 | €27,822 | ▼ 47.3% |
| Amounts receivable within one year40/41 | €204,227 | €43,265 | €7,520 | €4,914 | €8,186 | ▲ 66.6% |
| Trade receivables40 | €31,634 | €6,459 | €6,800 | - | €7,258 | - |
| Other amounts receivable41 | €172,593 | €36,806 | €720 | €4,914 | €928 | ▼ 81.1% |
| Cash at bank and in hand54/58 | €15,223 | €11,835 | €82,803 | €47,396 | €19,451 | ▼ 59.0% |
| Deferred charges and accrued income490/1 | €10,897 | €5,666 | €856 | €462 | €185 | ▼ 59.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €241,626 | €65,386 | €92,608 | €52,772 | €27,822 | ▼ 47.3% |
| Equity10/15 | -€651,326 | -€755,038 | -€781,109 | -€806,089 | -€879,841 | ▼ 9.1% |
| Contributions10/11 | €61,500 | €61,500 | €61,500 | €61,500 | €61,500 | = |
| Capital10 | €61,500 | €61,500 | €61,500 | €61,500 | €61,500 | = |
| Issued capital100 | €61,500 | €61,500 | €61,500 | €61,500 | €61,500 | = |
| Profit (loss) carried forward14 | -€712,826 | -€816,538 | -€842,609 | -€867,589 | -€941,341 | ▼ 8.5% |
| Amounts payable17/49 | €892,951 | €820,423 | €873,717 | €858,861 | €907,663 | ▲ 5.7% |
| Amounts payable within one year42/48 | €892,951 | €820,423 | €873,717 | €858,861 | €907,663 | ▲ 5.7% |
| Trade debts44 | €94,601 | €43,042 | €22,405 | €7,786 | €6,312 | ▼ 18.9% |
| Suppliers440/4 | €94,601 | €43,042 | €22,405 | €7,786 | €6,312 | ▼ 18.9% |
| Taxes, remuneration and social security45 | €44,146 | €13,817 | €7,748 | €7,911 | €8,188 | ▲ 3.5% |
| Taxes450/3 | €6,149 | €1,811 | €171 | €157 | €174 | ▲ 11.0% |
| Remuneration and social security454/9 | €37,998 | €12,006 | €7,577 | €7,754 | €8,013 | ▲ 3.3% |
| Other amounts payable47/48 | €754,204 | €763,564 | €843,564 | €843,164 | €893,164 | ▲ 5.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€143,300 | -€103,712 | -€26,071 | -€24,981 | -€73,752 | ▼ 195% |
| + Depreciation and write-downs630 | €6,291 | €6,659 | €3,191 | €1,429 | - | - |
| Operating cash flow (approximation) | -€137,009 | -€97,053 | -€22,881 | -€23,551 | -€73,752 | ▼ 213% |
| Investment in fixed assets (approximation) | - | €0 | €0 | - | - | - |
| Change in cash | - | -€3,387 | €70,968 | -€35,407 | -€27,945 | ▲ 21.1% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
21-09
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 52 days late
2025
19-09
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 50 days late
2024
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 29 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 31 days late
2022
13-10
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 74 days late
2021
21-12
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 143 days late
2020
31-12
Financial
Weakest financial yearnet -€234,691
Net result drops to -€234,691, the lowest in the series; recovery starts the following year.
30-11
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 122 days late
2019
21-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 21 days late
24-01
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 177 days late
2018
09-03
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 221 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 19 acts read
About the unread acts
We know of 19 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
19 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Charleroi · 1 establishment unit since 2004
Ground area
5,399 m²
Parcel 52028B0318/00G002, Wallonia. Linked by address, not a title deed.
1 establishment unit
DNAVision
since 20042.139.181.877
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52028B0318/00G002 | Wallonia | 5,399 m² | - | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
European research
4 projects · 1,009,493 EUR EU contributionProgrammes
Projects
Genome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer
Development of novel treatment strategies based on knowledge of cellular dysfunction in diabetes
Innovative Network for Next Generation Training and Sequencing of Virome
European Training Network on Cancer-Induced Bone Diseases
Similar companies · same sector, comparable size
ORSI Academy
BE 0829.147.981
Merelbeke-Melle · Eq €1,507,315
LARECO
BE 0444.719.066
Marche-en-Famenne · Eq €1,562,718
Data, AI and Robotics (DAIRO)
BE 0564.886.131
Brussel · Eq €1,569,534
THILIO
BE 0877.273.641
Lubbeek · Eq €1,576,035
Zymofix
BE 0788.847.055
Gent · Eq €1,581,088
Of 1,177 companies in sector 72109 we hold annual accounts for 717. 423 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded13-05-2004
Fiscal year end31-12
Activities, NACEBEL 2025
72101Research and development on biotechnology
72109Other research and development on natural sciences
E-invoicing
Reachable via Peppol
Peppol ID
0208:0865300475
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.